It was a very busy week for the Contemporary Pediatrics team.
This week’s top articles included:
It takes a village: Community interventions to address teen e-cigarette use
At the virtual 2021 American Academy of Pediatrics National Conference & Exhibition, Maria Rahmandar, MD, FAAP, reviews issues surrounding teen e-cigarette use in schools, along with methods to help teens quit.
Reaching teens on sexual health through telehealth
Telehealth offers a whole new way to reach out to adolescent patients for critical conversations on sexual health, according to a session at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition.
Persistent foot and leg swelling in a 17-year-old female
A 17-year-old girl presents with a 2-year history of unilateral swelling of the left lower extremity as well as a poorly healed ankle sprain of the affected extremity 3 years prior that slowly resolved but left persistent swelling. What's the diagnosis?
Available biologics for treating asthma and allergic skin disease
In cases of poorly controlled disease, even with good medication adherence, it might make sense to turn to biologics. A presentation at the virtual 2021 American Academy of Pediatrics National Conference & Exhibition covered biologics available for treating asthma and allergic skin disease.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.